恒瑞医药: 恒瑞医药2024年年度权益分派实施公告

Core Points - Jiangsu Hengrui Medicine Co., Ltd. announced a cash dividend of 0.2 RMB per share for its A shares, approved at the 2024 annual shareholders' meeting on April 28, 2025 [1][2] - The record date for the dividend distribution is May 22, 2025, with the ex-dividend date and cash dividend payment date both set for May 23, 2025 [1][2] - The total share capital participating in the distribution is 6,370,650,964 shares after excluding 8,351,310 shares held in the company's repurchase account [2] Dividend Distribution Details - The cash dividend distribution will be executed through the China Securities Depository and Clearing Corporation Limited, Shanghai Branch, with shareholders able to receive their dividends on the payment date if they have completed designated transactions [2][4] - The reference price for the ex-dividend date is calculated as the previous closing price minus the cash dividend, with no change in the number of circulating shares [2] - For individual shareholders holding shares for over one year, the cash dividend is exempt from personal income tax, while those holding for less than one year will have taxes calculated upon the sale of shares [4][5] Tax Implications - For qualified foreign institutional investors (QFII), a 10% corporate income tax will be withheld from the cash dividend, resulting in a net distribution of 0.18 RMB per share for Hong Kong Stock Exchange investors [5] - Other institutional investors are responsible for their own tax payments, with a gross cash dividend of 0.2 RMB per share [5]